Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction

Biochemical and Biophysical Research Communications

Volumn 281, Issue 5, 2001, Pages 1200-1206

  Fukui, Toshiki ^a   Yoshiyama, Minoru ^b   Hanatani, Akihisa ^b   Omura, Takashi ^b   Yoshikawa, Junichi ^b   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Osaka Metropolitan University   (Japan)

Author keywords

Lipid peroxidation; NADPH oxidase; NF B; Oxidative stress; Superoxide anion; Ventricular remodeling

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA BINDING; HEART INFARCTION; HEART VENTRICLE REMODELING; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0034805555     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4493     Document Type: Article

References (32)

1. Oxygen free radicals and congestive heart failure
2. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats
3. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective
4. Oxidative stress and cardiovascular disease
5. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
6. Cellular and molecular mechanisms of endothelial cell dysfunction
7. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells
8. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells
9. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats
10. Expression of NADH/NADPH oxidase p22phox in human coronary arteries
11. Experimental myocardial infarction in the rat: Qualitative and quantitative changes during pathologic evolution
12. Early and late effects of captopril treatment after large myocardial infarction in rats
13. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethyl-enediaminetetraacetic acid
14. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells
15. Interactions between the components of the human NADPH oxidase: Intrigues in the phox family
16. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits
17. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease
18. Cell transformation by the superoxide-generating oxidase Mox1
19. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells
20. Ventricular activation of the atrial natriuretic factor gene in acute myocardial infarction
21. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart
22. Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction
23. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction
24. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in tats
25. Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography
26. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: Role of oxidative stress
27. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
28. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B
29. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction
30. Increased activity of nuclear factor-κB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats
31. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats
32. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling